Maria Emília Juan Olive

Dr. Maria Emília Juan Olive

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2002 in The Journal of Nutrition
Verified
Journal Article
Open access
PDF file
MOMaria Emília Juan Olive
Maria Emília Juan Olive
Maria Pilar VinardellMaria Pilar Vinardell
Maria Pilar Vinardell
JPJoana M. Planas
Joana M. Planas
trans-3,5,4′-Trihydroxystilbene (trans-resveratrol) is a phytochemical present in peanuts, grapes and wine with beneficial effects such as protection against cardiovascular disease and cancer prevention. The purpose of this study was to evaluate whether high doses of trans-resveratrol have harmful effects on Sprague-Dawley rats. trans-Resveratrol was administered orally to male rats for 28 d at a dose of 20 mg/(kg · d), 1000 times the amount consumed by a 70-kg person taking 1.4 g of trans-resveratrol/d. Body weight, and food and water consumption did not differ between rats treated with trans-resveratrol and the control group. Hematologic and biochemical variables were not affected by the treatment. Histopathologic examination of the organs obtained at autopsy did not reveal any alterations. These results support the view that repeated consumption of trans-resveratrol at 20 mg/(kg · d) does not adversely affect the variables tested in rats.

1 June 2008 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
MOMaria Emília Juan Olive
Maria Emília Juan Olive
UWUwe Wenzel
Uwe Wenzel
HDHannelore Daniel
Hannelore Daniel
JPJoana M. Planas
Joana M. Planas

1 January 2010 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
MOMaria Emília Juan Olive
Maria Emília Juan Olive
MMMonica Maijó
Monica Maijó
JPJoana M. Planas
Joana M. Planas

1 July 2008 in British Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
MOMaria Emília Juan Olive
Maria Emília Juan Olive
JPJoana M. Planas
Joana M. Planas
VRValentina Ruiz-Gutierrez
Valentina Ruiz-Gutierrez
HDHannelore Daniel
Hannelore Daniel
UWUwe Wenzel
Uwe Wenzel
We have previously reported the anticarcinogenic effects of an olive fruit extract composed of pentacyclic triterpenes, the main components of which are maslinic acid (73·25 %) and oleanolic acid (25·75 %). Here we examined the effects of the individual components on proliferation, necrosis and apoptosis rates by fluorescence-based techniques in human HT-29 colon cancer cells. Oleanolic acid showed moderate antiproliferative activity, with an ec50 of 160·6 (se 10·6) μmol/l, and moderate cytotoxicity at high concentrations ( ≥ 250 μmol/l). On the other hand, maslinic acid inhibited cell growth with an ec50 of 101·2 (se 7·8) μmol/l, without necrotic effects. Oleanolic acid, which lacks a hydroxyl group at the carbon 2 position, failed to activate caspase-3 as a prime apoptosis protease. In contrast, maslinic acid increased caspase-3-like activity at 10, 25 and 50 μmol/l by 3-, 3·5- and 5-fold over control cells, respectively. The detection of ROS in the mitochondria, which serve as pro-apoptotic signal, evidenced the different bioactivity of the two triterpenes. Confocal microscopy analysis revealed that maslinic acid generated superoxide anions while oleanolic acid-treated cells did not differ from the control. Completion of apoptosis by maslinic acid was confirmed microscopically by the increase in plasma membrane permeability, and detection of DNA fragmentation. In conclusion, the anticancer activity observed for olive fruit extracts seems to originate from maslinic acid but not from oleanolic acid. Maslinic acid therefore is a promising new compound for the chemoprevention of colon cancers.

4 August 2014 in Molecules
Verified
Journal Article
Open access
PDF file
GMGloria Lozano Mena
Gloria Lozano Mena
MSMarta Sánchez-González
Marta Sánchez-González
MOMaria Emília Juan Olive
Maria Emília Juan Olive
JPJoana M. Planas
Joana M. Planas
Maslinic acid is a pentacyclic triterpene found in a variety of natural sources, ranging from herbal remedies used in traditional Asian medicine to edible vegetables and fruits present in the Mediterranean diet. In recent years, several studies have proved that maslinic acid exerts a wide range of biological activities, i.e. antitumor, antidiabetic, antioxidant, cardioprotective, neuroprotective, antiparasitic and growth-stimulating. Experimental models used for the assessment of maslinic acid effects include established cell lines, which have been often used to elucidate the underlying mechanisms of action, and also animal models of different disorders, which have confirmed the effects of the triterpene in vivo. Overall, and supported by the lack of adverse effects in mice, the results provide evidence of the potential of maslinic acid as a nutraceutical, not only for health promotion, but also as a therapeutic adjuvant in the treatment of several disorders.

1 April 2005 in The Journal of Nutrition
Verified
Journal Article
Open access
PDF file
MOMaria Emília Juan Olive
Maria Emília Juan Olive
EGEulalia González-Pons
Eulalia González-Pons
TMThais Munuera
Thais Munuera
JBJoan Ballester
Joan Ballester
Joan E. Rodríguez-GilJoan E. Rodríguez-Gil
Joan E. Rodríguez-Gil
JPJoana M. Planas
Joana M. Planas
trans-Resveratrol was reported to have health benefits including anticarcinogenic effects and protection against cardiovascular disease. One of the mechanisms by which it exerts its action is through modulating the estrogen response systems. Because estrogen is involved in male reproductive biology, we investigated the effect of trans-resveratrol on testis and spermatogenesis. Adult male rats were divided into 2 groups. The treated group was administered by gavage 20 mg/(kg · d) of trans-resveratrol suspended in 10 g/L of carboxymethylcellulose for 90 d, whereas the control group received only carboxymethylcellulose during the same period. The relative weight of testes did not differ between the groups. However, the diameter of the seminiferous tubules was significantly reduced from 437.5 ± 0.1 μm in the controls to 310.9 ± 0.1 μm in the resveratrol–treated rats. This decrease was accompanied by a significant increase in tubular density, from 3.20 ± 0.18 in controls to 6.58 ± 0.18 tubules/mm2 in the treated group. Moreover, sperm counts were significantly greater in the resveratrol-treated rats (24.8 ± 3.30 × 107) than in the control group (14.1 ± 0.80 × 107), but sperm quality did not differ. Serum concentrations of gonadotrophins and testosterone were significantly higher in the resveratrol-treated group. We identified a novel activity of trans-resveratrol. The daily oral administration of this phytochemical to adult male rats enhanced sperm production by stimulating the hypothalamic-pituitary-gonadal axis, without inducing adverse effects.